Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 8, 2006, Pages 725-733

  Al Majed, Abdulhakeem A ^a   Sayed Ahmed, Mohamed M ^a   Al Omar, Fadhal A ^a   Al Yahya, Abdulaziz A ^a   Aleisa, Abdulaziz M ^a   Al Shabanah, Othman A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adenosine triphosphate; Carnitine esters; Forebrain ischaemia; Hippocampal CA1; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUTATHIONE; LEVACECARNINE; NITRATE; NITRITE; PROPIONYLCARNITINE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL COUNT; CONTROLLED STUDY; ENERGY BALANCE; ENERGY METABOLISM; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NERVE CELL; NERVE CELL LESION; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; STATISTICAL SIGNIFICANCE;

ACETYLCARNITINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CARNITINE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUTATHIONE; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; NITRATES; NITRITES; OXIDATIVE STRESS; PROSENCEPHALON; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33745943818     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04425.x     Document Type: Article

References (61)

1. Levy DE, Caronna JJ, Singer BH, Lapinski RH, Frydman H, Plum F. Predicting outcome from hypoxic-ischemic coma. JAMA 1985; 253: 1420-6.
2. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987; 37: 1281-6.
3. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982; 239: 57-69.
4. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 1982; 11: 491-8.
5. Kirino T. Delayed neuronal death. Neuropathology 2000; 20 (Suppl.): S95-7.
6. Colbourne F, Li H, Buchan AM. Continuing postischemic neuronal death in CA1: Influence of ischemia duration, and cytoprotective doses of NBQX and SNX-111. Stroke 1999; 30: 662-8.
7. Katsura K, Kristian T, Smith ML, Siesjö BK. Acidosis induced by hypercapnia exaggerates ischemic brain damage. J. Cereb. Blood Flow Metab. 1994; 14: 243-50.
8. Iadecola C, Pelligrin DA, Moskwitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 1994; 14: 175-92.
9. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 2001; 21: 2-14.
10. Evans PH. Free radicals in brain metabolism and pathology. Br. Med. Bull. 1993; 49: 577-87.
11. Goa KL, Brogden RN. L-Carnitine. Drugs 1987; 34: 1-24.
12. Vanella A, Russo A, Acquaviva R et al. L-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol. Toxicol. 2000; 16: 99-104.
13. Rani PJ, Panneerselvam C. Carnitine as a free radical scavenger in aging. Exp. Gerontol. 2001; 36: 1713-26.
14. Yasui F, Matsugo S, Ishibashi M. Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice. Neurosci. Lett. 2002; 334: 177-80.
15. Arafa HMM, Sayed-Ahmed MM. Protective role of carnitine esters against alcohol-induced gastric lesions in rats. Pharmacol. Res. 2003; 48: 285-90.
16. Shug AL, Schmidt MI, Golden GT, Fariello RT. The distribution and role of carnitine in the mammalian brain. Life Sci. 1982; 31: 2869-74.
17. Nalecz KA, Nalecz MJ. Carnitine: A known compound, a novel function in neural cells. Acta Neurobiol. Exp. 1996; 56: 597-609.
18. Kido Y, Tamai I, Ohnari A et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J. Neurochem. 2001; 79: 959-69.
19. Friedrich A, Prasad PD, Freyer D, Ganapathy V, Brust P. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier. Brain. Res. 2003; 968: 69-79.
20. Lolic MM, Fiskum G, Rosenthal RE. Neuroprotective effects of acetyl L-carnitine after stroke in rats. Ann. Emerg. Med. 1997; 29: 758-65.
21. Shuaib A, Waqaar T, Wishart T, Kanthan R, Hewlett W. Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. Neurochem. Res. 1995; 20: 1021-5.
22. Rosenthal RE, Williams R, Bogaert YE. Prevention of post-ischemic canine neurological injury through poteniation of brain energy metabolism by acetyl-L-carnitine. Stroke 1992; 23: 1312-17.
23. Ishii T, Shimpo Y, Matsuoka Y, Kinoshita K. Anti-apoptotic effect of acetyl L-carnitine and L-carnitine in primary cultured neurons. Jpn. J. Pharmacol. 2000; 83: 119-24.
24. Packer L, Valenza M, Serbinova E, Starke-Reed P, Frost K, Kagan V. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch. Biochem. Biophys. 1991; 288: 533-7.
25. Reznick AZ, Kagan VE, Ramsey R et al. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: The possible role of iron chelation. Arch. Biochem. Biophys. 1992; 296: 394-401.
26. Caruso A, Cutuli VM, Bernardis E, Leonardi G, Amico-Roxas G. Protective effect of propionyl L-carnitine against PAF-induced rat paw oedema. Pharmacol. Res. 1995; 31: 67-72.
27. Paulson DJ, Traxler J, Schmidt M, Noonan J, Shug AL. Protection of the ischemic myocardium by L-propionylcarnitine: Effects on the recovery of cardiac output after ischemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc. Res. 1986; 20: 536-41.
28. Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak-Szydlowska W. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc. Res. 2001; 51: 21-9.
29. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: A review. Ann. N.Y. Acad. Sci. 2004; 1033: 79-91.
30. Siliprandi N, Di Lisa F, Pivetta A, Miotto G, Siliprandi D. Transport and function of L-carnitine and L-propionylcarnitine: Relevance to some cardiomyopathies and cardiac ischemia. Z. Kardiol. 1987; 76: 34-40.
31. Cevese A, Schena F, Cerutti G. Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs. Cardiovasc. Drugs Ther. 1991; 5: 45-56.
32. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK. Models for studying long term recovery following forebrain ischemia in the rat, II: A 2-vessel occlusion model. Acta Neurol. Scand. 1984; 69: 385-401.
33. Henrich-Noack P, Prehn JHM, Krieglstein J. TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia: Dose-response relationship and potential neuroprotective mechanisms. Stroke 1996; 27: 1609-15.
34. Ohkawa H, Ohish N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal. Biochem. 1979; 95: 351-8.
35. Ellman GL. Tissue sulfahydryl groups. Arch. Biochem. Biophys. 1959; 82: 70-7.
36. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide Biol. Chem. 2001; 5: 62-71.
37. Botker HE, Kimose M, Helligso P, Nielsen TT. Analytical evaluation of high-energy phosphate determination by high performance liquid chromatography in myocardial tissue. J. Mol. Cell. Cardiol. 1994; 26: 41-8.
38. Knuckey NW, Palm D, Primiano M, Epstein MH, Johanson CE. N-Acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke 1995; 26: 305-11.
39. Crumrine RC, La Manna JC. Regional cerebral metabolites, blood flow, plasma volume, and mean transit time in total cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 1991; 11: 272-82.
40. Sims NR, Zaidan E. Biochemical changes associated with selective neuronal death following short-term cerebral ischemia. Int. J. Biochem. Cell Biol. 1995; 27: 531-50.
41. Arai H, Passonneau JV, Lust WD. Energy metabolism in delayed neuronal death of CA1 neurons of the hippocampus following transient ischemia in the gerbil. Metab. Brain Dis. 1986; 1: 263-78.
42. Katayama Y, Welsh FA. Effect of dichloroacetate on regional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain. J. Neurochem. 1989; 52: 1817-22.
43. Al Nita D, Nita V, Spulber S et al. Oxidative damage following cerebral ischemia depends on reperfusion: A biochemical study in rat. J. Cell. Mol Med. 2001; 5: 163-70.
44. Al-Majed AA. Aminoguanidine prevents oxidative stress insult following transient forebrain ischemia in the rat hippocampus. Saudi Pharm. J. 2004; 12: 179-85.
45. Al-Majed AA, Al-Yahya AA, Asiri YA, Al-Gonaiah MA, Mostafa AM. Nimesulide prevents oxidative stress damage following transient forebrain ischemia in the rat hippocampus. Res. Commun. Mol. Pharmacol. Pathol. 2006 (in press).
46. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA 1990; 87: 1620-4.
47. Iadecola C. Dark and bright sides of nitric oxide in ischemic brain injury. Trends. Neurosci. 1997; 20: 132-9.
48. 1H-NMR spectroscopy. Brain Res. 1994; 643: 92-9.
49. Calvani M, Arrigoni-Martelli E. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int. J. Tissue React. 1999; 21: 1-6.
50. Bogaart YE, Rosenthal RE, Fiskum G. Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. Free Radic. Biol. Med. 1994; 16: 811-20.
51. Abdel-aleem S, Sayed-Ahmed MM, Nada MA et al. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes. J. Mol. Cell. Cardiol. 1995; 28: 825-33.
52. Davis EJ, Spydevoid O, Bremer J. Pyruvate carboxylase and proionyl-CoA carboxylase as anaplerotic enzymes in skeletal muscle mitochondria. Eur. J. Biochem. 1980; 110: 255-62.
53. Ferrari R, De Giuli F. The propionyl-L-carnitine hypothesis: An alternative approach to treating heart failure. J. Cardiac Fail. 1997; 32: 17-24.
54. Wainwright MS, Mannix MK, Brown J, Stumpf DA. L-Carnitine reduces brain injury after hypoxia-ischemia in newborn rats. Pediatr. Res. 2003; 54: 1-8.
55. Vary T, Neely J. Characterization of carnitine transport in isolated perfused adult rat hearts. Am. J. Physiol. 1982; 242: H585-92.
56. Huth P, Shug A. Characterization of carnitine transport in rat kidney cortex brain slices. Biochem. Biophys. Acta 1980; 602: 621-34.
57. Huth P, Schmidt M, Hall P, Fariello R, Shug A. The uptake of carnitine by slices of rat cerebral cortex. J. Neurochem. 1981; 36: 715-23.
58. Tanaka Y, Sasaki R, Fukui F et al. Acetyl-L-carnitine supplementation restores decreased tissue carnitine levels and impaired lipid metabolism in aged rats. J. Lipid Res. 2004; 45: 729-35.
59. Mister N, Noris M, Szymczuk J et al. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int. 2002; 61: 1064-78.
60. Sharman EH, Vaziri ND, Ni Z, Sharman KG, Bondy SC. Reversal of biochemical and behavioral parameters of brain aging by melatonin and acetyl-L-carnitine. Brain Res. 2002; 957: 223-30.
61. Salvemini D, Wang Z, Wyatt PS et al. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 1996; 118: 829-38.